Delivery Order SPE2DE21D7020-SPE2D625F2YL7
- Not listed
- This delivery order, valued at $5,214.96, was awarded to Boston Scientific Corp on July 29, 2025, for the supply of Ranger Global DCB (drug-coated balloon) OTW (over-the-wire) devices measuring 5.0 x 200mm with a 150cm length. The contract is funded through the Defense Health Agency's Medical Supply Chain division and employs fixed-price pricing with economic price adjustment terms. Performance will occur at Boston Scientific's facility in Marlborough, Massachusetts, with an ultimate...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $5,710.95 to Boston Scientific Corp for Ranger Global drug-coated balloon (DCB) devices measuring 5.0 x 200mm with a 90cm length. This fixed-price contract with economic price adjustment provisions was awarded on September 19, 2025, with an ultimate completion date of September 26, 2025. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, and no small business set-aside was...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $55,947.15 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, which carries no set-aside designation, calls for the delivery of Ranger Global DCB (drug-coated balloon) devices measuring 4.0 x 120mm with a 150cm length. Performance will take place at Boston...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order contract valued at $1,974.29 by the Defense Health Agency's Medical Supply Chain on July 2, 2025, with an ultimate completion date of July 10, 2025. The contract, issued without a set-aside designation, covers the procurement of a Ranger Global DCB (drug-coated balloon) OTW (over-the-wire) 7.0 x 60mm 80cm medical device. The contract employs fixed-price...
- Boston Scientific Corp was awarded a $26,303.48 fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain on June 10, 2025, for the supply of Ranger Global DCB (Drug-Coated Balloon) orthopedic/thoracic wound care products (7.0 x 200mm, 150cm). The contract is not set-aside and calls for completion by June 17, 2025, with performance taking place at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a...
- Boston Scientific Corp has been awarded a delivery order valued at $10,060.61 for Ranger Global DCB OTW 5.0 x 40mm 135cm medical devices under a fixed-price contract with economic price adjustment provisions. The award, issued on July 11, 2025, with an ultimate completion date of July 18, 2025, will be performed at Boston Scientific's facilities in Marlborough, Massachusetts. This delivery order was issued without set-aside restrictions, allowing Boston Scientific to compete openly in the...
- This is a $43,399.46 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts. The contract is for the delivery of RANGER GLOBAL DCB OTW 5.0 X 200MM 150CM medical devices, which are drug-coated balloons used for cardiovascular procedures. This contract is not set aside and is part of Boston Scientific's broader portfolio of federal contracts with agencies like the...
- Boston Scientific Corp has been awarded a delivery order valued at $1,974.29 by the Defense Health Agency's Medical Supply Chain for the procurement of Ranger Global DCB OTW 6.0 x 100mm 135cm medical devices. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and carries an ultimate completion date of September 22, 2025. The award was made without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace....
- Boston Scientific Corp has been awarded a delivery order by the Defense Health Agency's Medical Supply Chain for RANGER GLOBAL DCB OTW 4.0 x 120MM 150CM medical devices, with a ceiling value of $30,554.50 under a fixed-price contract with economic price adjustment provisions. The award was made on August 4, 2025, with an ultimate completion date of August 11, 2025. This is an open competition contract with no set-aside designation, and the place of performance is Boston Scientific's facility...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $13,356.93 for drug-coated balloons under a fixed-price contract with economic price adjustment provisions. The award was issued on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract was funded by the Defense Health Agency's Medical Supply Chain and represents an open competition award with no set-aside designation. Drug-coated balloons are...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F2YL7Delivery Order
Boston Scientific Corp has been awarded a delivery order valued at $2,981.31 for RANGER GLOBAL DCB (drug-coated balloon) 7.0 x 150mm devices, 150cm in length, under a fixed price contract with economic price adjustment provisions. The award, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is funded through the Defense Health Agency's Medical Supply Chain and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order was not designated as a set-aside contract, indicating the award was made through open competition in the federal marketplace. This contract represents a routine procurement of specialized cardiovascular intervention medical devices for federal healthcare agencies, consistent with Boston Scientific's established role as a primary supplier of advanced medical technologies to the Department of Defense Health Agency and related federal medical systems. The drug-coated balloon devices are used in interventional cardiology procedures and support the federal government's objective of maintaining critical medical supply chains across defense healthcare networks. The short completion timeline and relatively modest contract value indicate this is a discrete delivery order likely fulfilling an immediate operational need within the DHA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 6/18/25 |